Metronidazole Noridem

Metronidazole, the active ingredient in Metronidazole Noridem, is a nitroimidazole antibiotic presented as an intravenous solution for intravenous use. It treats a range of anaerobic bacterial and protozoal infections in adult patients, including bacterial vaginosis, trichomoniasis, amoebiasis, intra‑abdominal infections, and pelvic inflammatory disease.

GNH USA supplies Metronidazole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality compliance with EU standards and reliable cold‑chain logistics where required through its global distribution network.

Metronidazole is a nitroimidazole antibiotic that targets anaerobic bacteria and susceptible protozoa, making it useful for several infection types.

- Anaerobic bacterial infections: effective treatment of intra‑abdominal, pelvic and other infections caused by anaerobic organisms. - Bacterial vaginosis: eradicates the bacterial flora responsible for the condition. - Trichomoniasis: eliminates Trichomonas vaginalis in affected patients. - Amoebiasis: clears intestinal and extra‑intestinal Entamoeba infections. - Intra‑abdominal infections: controls mixed aerobic‑anaerobic infections after surgery. - Pelvic inflammatory disease: reduces pathogenic anaerobes contributing to PID.

Metronidazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: persistent metallic sensation in the mouth. - Headache: occasional mild to moderate headache. - Diarrhea: loose stools during therapy.

Serious or Rare Side Effects: - Seizures: rare neurologic events, especially with high doses. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis, rash, or angioedema.

Metronidazole requires careful use in specific patient populations and clinical situations. - Assess renal function: adjust therapy in severe impairment. - Monitor hepatic function: watch for signs of liver toxicity. - Avoid use in first trimester: limited safety data for early pregnancy. - Use with caution in CNS disorders: increased risk of seizures. - Store at ambient temperature: keep in original container, protect from light and moisture.

Metronidazole can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Alcohol: may cause a disulfiram‑like reaction with flushing and tachycardia. - Warfarin: increased anticoagulant effect, raising bleeding risk. - Lithium: heightened lithium toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Cimetidine: may raise metronidazole plasma levels. - Phenytoin: may reduce metronidazole effectiveness.